用户名: 密码: 验证码:
肝气郁结证、肝火上炎证患者情绪测量及与5-HTT,TPH,ACE基因多态性相关研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:探讨肝气郁结证,肝火上炎证患者的情绪状态特征及与5-HTT,TPH,ACE基因多态性相关的分子遗传机理。
     方法:1、病证结合选择研究对象,按异病同证和同病异证分组,采用中医肝脏象情绪量表及Beck焦虑量表、Beck抑郁量表对203例肝气郁结证、肝火上炎证、肝气虚证、肝阳上亢证患者及90例健康人对照进行情绪测量。2、运用多聚酶链式反应技术(PCR)检测5-HTT启动子区(5-HTTLPR)、5-HTT基因内含子2 VNTR、TPH基因内含子7 A218C及ACE基因插入/缺失(I/D)四种基因多态性在四种中医证型中的分布频率,并与健康人对照组比较。
     结果:1、肝气郁结证、肝火上炎证、肝气虚证、肝阳上亢证患者中医肝脏象情绪量表、Beck焦虑量表、Beck抑郁量表测值各项积分均明显高于健康人对照组(P<0.01)。2、异病同证比较,中医肝脏象情绪量表肝经维度和焦虑维度,肝阳上亢证和肝火上炎证明显高于肝气郁结证和肝气虚证,差异有显著性(P<0.01);抑郁维度方面,肝气郁结证明显高于肝阳上亢证组,差异有显著性(P<0.05);总分方面,肝火上炎证明显高于肝气虚证,差异有显著性(P<0.01)。Beck焦虑量表积分,肝火上炎证明显高于肝气郁结证和肝气虚证,差异有显著性(P<0.01);Beck抑郁量表积分,肝气郁结证、肝气虚证高于肝阳上亢证(P<0.01,P<0.05)。3、神经症同病异证四种中医证型之间比较,中医肝脏象情绪量表肝经维度积分肝阳上亢证和肝火上炎证明显高于肝气虚证(P<0.01);焦虑维度及Beck焦虑量表积分,肝火上炎证最高,肝气虚证最低,但四种证型差异无显著性;抑郁维度及Beck抑郁量表积分,肝气郁结证高于肝阳上亢证(P<0.01,P<0.05)。4、5-HTTLPR基因多态性分布频率异病同证比较,肝火上炎证、肝阳上亢证患者组与健康人组基因型分布频率差
    
    异有显著性(HO.026,HO.025人 两证的钻基因型频率明显高于
    健康人组02伽S49儿 69VS49肋;肝火上炎证患者组与健康人组等
    位基因频率差异有显著性(HO 009人 肝火上炎证患者的S等位基
    因频率明显高于健康人组抢5伽S71趾;神经症同病异证比较结果类
    似,肝火上炎证、肝阳上亢证患者组的SS基因型频率明显高于健康
    人组(80%VS49%HO.021,72VS49% HO.009);肝火上炎证患者的 S
    等位基因频率明显高于健康人组瞩8伽S71%HO.015人肝气郁结证、
    肝气虚证患者组与健康人组比较各基因型和等位基因频率均差异无
    显著性(ho.05)。5、5-HT基因内含子 2 VNTR、TPH基因内含子 7 A218C
    及 ACE内含子 161川型多态性在四种中医证型中的分布频率无显著
    性差异(NO.05人
     结论:1、肝气郁结证、肝火上炎证及其对照证候肝气虚证、肝
    阳上亢证患者均具有不同程度的焦虑、抑郁情绪状态。2、肝火上炎
    证和肝阳上亢证患者的焦虑程度要高于肝气郁结证和肝气虚证患
    者。3、肝气郁结证患者的抑郁程度要高于肝阳上亢证患者。4、
    5干TTLPR多态性%型个体可能是肝火上炎证和肝阳上亢证的易感
    人群。
Objective To explore the emotional characteristics of patients with hepatic depression syndrome and hyperpyrexia of liver syndrome and the relationship between the syndroms and polymorphisms in the serotonin transporter(5-HTT), tryptophan hydroxylase(TPH), and angiotensin converting enzyme(ACE) genes
    Methods 1. The patients were selected by considering not only their western medicine diagnosis but also their Traditional Chinese Medicine (TCM) diagnosis. Their emotion state were measured with Emotions Rating Scale for Ganzangxiang of traditional Chinese medicine(ERSG), Beck anxiety inventory(BAI) and Beck depression inventory (BDI) in 90 healthy subjects and 203 patients with hepatic depression syndrome, hyperpyrexia of liver syndrome, deficiency of hepatic Qi syndrome, or hyperhepatic Yang syndrome.
    2. Using a polymerase chain reaction-based technique, the frequencies of 5-HTTLPR, 5-HTT intron2 VNTR, TPH intron7 A218C, and ACE intron 16 insertion/deletion (I/D) polymorphisms were determined in all patient groups and control subjects. Genotype and allele frequency comparisons between patient groups and control subjects were carried out with chi-square tests or Fisher's exact tests.
    Results 1. The accumulating scores of three dimensions in ERSG, BAI and BDI of all patients were significantly higher than that of controls (PO.01) .
    2. When comparisons were carried out in all patients with different syndrome of TCM, the scores of Ganjing dimension and anxiety dimension in ERSG were higher in patients with hyperhepatic Yang
    
    
    
    syndrome and hyperpyrexia of liver syndrome than that with deficiency of hepatic Qi syndrome and hepatic depression syndrome (P<0.01); The scores of depression dimension in ERSG were significantly higher in patients with hepatic depression syndrome than that with hyperhepatic Yang syndrome (P<0.01) ; the total scores of ERSG were significantly higher in patients with hyperpyrexia of liver syndrome than that with deficiency of hepatic Qi syndrome (P<0.01) ; the scores of BAI were higher in patients with hyperpyrexia of liver syndrome than that with deficiency of hepatic Qi syndrome and hepatic depression syndrome (P<0.01) ; The scores of BDI were significantly higher in patients with hepatic depression syndrome and deficiency of hepatic Qi syndrome than that with hyperhepatic Yang syndrome (P<0.01, P<0.05) .
    3. When comparation were carried out in neurosis patients, the scores of Ganjing dimension in ERSG were higher in patients with hyperhepatic Yang syndrome and hyperpyrexia of liver syndrome than that with deficiency of hepatic qi syndrome. The scores of anxiety dimension in ERSG and BAI were similar in patients with four liver syndromes. The scores of depression dimension in ERSG and BDI were significantly higher in patients with hepatic depression syndrome than that with hyperhepatic Yang syndrome.
    4. When comparisons were carried out in all patients with different syndrome of TCM, the frequencies of 5-HTTLPR short/short (SS) genotype were significantly higher in patients with hyperpyrexia of liver syndrome and hyperhepatic Yang syndrome than in control subjects (72%vs49%, P=0.026; 69vs49%, P=0.025), and the S allele frequencies were significantly higher in patients with hyperpyrexia of liver syndrome than in control subjects(85% vs 71%, P=0.009). Similar
    
    
    
    
    results were observed when comparation were carried out in neurosis patients, the frequencies of 5-HTTLPR short/short (SS) genotype were significantly higher in patients with hyperpyrexia of liver syndrome and hyperhepatic Yang syndrome than in control subjects (80%vs49%, P=0.021; 72vs49%, P=0.009), and the S allele frequencies were significantly higher in patients with hyperpyrexia of liver syndrome than in control subjects(88% vs 71%, P=0.015). However, there were no differences for the distribution of 5-HTTLPR between patients with deficiency of hepatic Qi syndrome and hepatic depression syndrome and controls.
    5. No significant differences for the genotype distribution or the allele frequency of 5-HTT intr
引文
[1] 王米渠著.中医心理学纲要.成都:四川科学技术出版社,1988.76-79
    [2] 赵玉秋,陈国林,潘其民,等.流行病学调查在肝病证候研究中应用.中医杂志,1991,32(3):49-51
    [3] 刘湘华,胡随瑜.肝阳上亢证患者个性、情绪特征及血浆精氨酸加压素水平的初步研究.湖南医科大学学报,1998,23(1):31-33
    [4] 陈泽奇,胡随瑜,刘盛.肝气郁结证患者Beck焦虑、抑郁量表测量结果分析.湖南中医学院学报,2000,(1):4-5
    [5] 施和勋.肝气郁结患者症状自评量表(SCL-90)评定结果分析.浙江中西医结合杂志,1999,9(2):85-86
    [6] 胡随瑜,王哲,尤劲松等.中医肝脏象情绪量表的初步编制.中国临床心理学杂志,2001,9(2):84-86
    [7] 王哲,胡随瑜,蔡太生.中医肝脏象情绪量表因子结构的研究.中国心理卫生杂志,2003,(3)
    [8] 王哲,胡随瑜,蔡太生等.中医肝脏象情绪量表的编制.中国中西医结合杂志,待发表
    [9] Mellerup E, Bennike B, Bolwig T, et al. Platelet serotonin transporters and the transporter gene in control subjects, unipolar patients and bipolar patients. Acta psychiatr scand, 2001, 103(3): 229-233
    [10] Bellivier F, Szoke A, Henry C, et al. Possible association between serotonin transporter gene polymorphism and violent suicided behavior in mood disorders. Biol Psychiatry, 2000, 48(4): 319-322
    [11] Mann JJ, Huang YY, Underwood MD, et al. A serotonin transporter gene promoter polymorphism and prefrontal cortical binding in major depression and suicide. ArchGen psychiatry, 2000, 57(8): 729-738
    [12] Kaiser R, Tremblay PB, Schmider J, et al. Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Mol Psychiatry, 2001, 6(2): 179-185
    
    
    [13] Hranilovic D, Schwab SG, Jernej B, et al. Serotonin transporter gene and schizophrenia: evidence for association/linkage disequilibrium in families with affected siblings. Mol Psychiatry, 2000, 5(1): 91-95
    [14] Chong SA, Lee WL, Tan CH, et al. Attemped suicide and polymorphism of the serotonin transporter gene in Chinese patients with schizophrenia. Psychiatry Res, 2000, 97(23): 101-106
    [15] Twitchell GR, Hanna GL, Cook EH, et al. Serotonin transporter promoter polymorphism genotype is associated with behavioral disinhibition and negative affect in children of alcoholics. Alcohol Clin Exp Res, 2001, 25(7): 953-959
    [16] Matsushita S, Yoshino A, Murayama M, et al. Association study of serotonin transporter gene regulatory region polymorphism and alcoholism. Am J Med Genet, 2001, 105(5): 446-450
    [17] Lichtermann D, Hranilovic D, Trixler M, et al. Support for allelic association of a polymorphic site in the promoter region of the serotonin transporter gene with risk for alcohol dependence. Am J Psychiatry, 2000, 157(12): 2045-2047
    [18] Gorwood P, Batel P, Ades J, et al. Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol Psychiatry, 2000, 48(4): 259-264
    [19] Greenberg BD, LiQ, Lucas FR, et al. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet, 2000, 96(2): 202-216
    [20] Samochowiec J, Rybakowski F, Czerski P, et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter fenes and their relationship to temperamental dimensions measures by the Temperament and Character Inventory in healthy volunteers. Neuropsychobiology, 2001, 43(4): 248-253
    [21] Melke J, Landen M, Baghei F, et al. Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. Am J Med Genet, 2001, 105(5): 458-463
    
    
    [22] Jorm AF, Prior M, Sanson A, et al. Association of functional olymorphism of the serotonin transporter gene with anxiety related temperament and behavior problems in children: a longiludinal study from infancy to the mid-teens. Mol Psychiatry, 2000, 5(5): 542-547
    [23] Bellivier F, Leboyer M, Courter P, et al. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gene Psychiatry, 1998, 55(1): 33-37.
    [24] Manuck SB, Flory JD, Ferrell RE, et al. Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry, 1999, 45(5): 603-614
    [25] Furlong RA, Ho L, Rubinsztein JS, et al. No association of tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder. American Journal of Medical Genetics, 1998, 81(3):245-247
    [26] Zalsman G, Frisch A, King RA, et al. Case control and family-based studies of tryptophan hydroxylase gene A218C polymorphism and suicidality in adolescents. American Journal of Medical Genetics, 2001, 105(5): 451-457
    [27] Arinami T, Li LM, Mitsushio H, et al. An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorder. Bio Psychiatry, 1996, 40(11):1122-1127
    [28] Ouyang WC, Wang YC, Hong CJ, et al. Association study of angiotensin-converting enzyme gene polymorphism with schizophrenia and polydipsia. Neuropsychobiology, 2001, 44(1):31-35
    [29] 金益强,主编.中医肝脏象现代研究与临床.第1版.北京:人民卫生出版社,2000.235-242
    [30] 中华精神科学会.中国精神疾病分类方案与诊断标准.第2版修订版.南京:南京大学出版社,1995.
    [31] Headache classification committee of the international headache society. Classification and diagnosis criteria for headache disorder,
    
    cranial neuralgias and facial pain. Cephalalgia, 1988, 8(suppl 7):1-96
    [32] Guidelines subcommittee. 1999 World Health Organization/International Society of Hypetension guidelines for the management of hypertension guidelines subcommitee. Journal of Hypertension, 1999, 17(1):151
    [33] 汪向东,主编.心理卫生评定量表手册.增订版.中国心理卫生杂志社,1999.191-194,251-252
    [34] 姜泊,等主编.分子生物学常用实验方法.第1版.北京:人民军医出版社,1996.66
    [35] 卢圣栋主编.现代分子生物学实验技术.第2版.北京:中国协和医科大学出版社,1999.102-103
    [36] Kirov G, Rees M, Jones I, et al. Bipolar disorder and the serotonin transporter gene: a family-based association study. Psychological Medicine, 1999, 29(5): 1249-1254
    [37] Deary IJ, Battersby S, Whiteman MC, et al. Neuroticism and polymorphisms in the serotonin transporter gene. Psychological Medicine, 1999, 29(3): 735-739
    [38] Collier DA, Stober G, Li T, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Mol Psychiatry, 1996, 1(6): 453-460
    [39] Ogilvie AD, Battersby S, Bubb VJ, et al. Polymorphism in serotonin tromsporter gene associated with susceptibility to major depression. Lacent, 1996, 347(9003): 731-733
    [40] Kunugi H, Hattori M, Kato T, et al. Serotonin transporter gene polymorphisms: ethic difference and possible association with bipolar affective disorder. Mol Psychiatry, 1997, 2(6): 457-462
    [41] Mendes de Oliveira JR, Otto PA, Vallada H, et al. Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene in Brazilian patients affected by bipolar disorder and schizophrenia. Am J Med Genet, 1998, 81(3): 225-227
    
    
    [42] Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest, 1990, 86(4): 1343-1346
    [43] 王谷亮,韩战营,朱鼎良,等.血管紧张素转换酶基因插入/缺失多态性检测方法的研究.中华心血管病杂志,2001,29(4):239-242
    [44] 印会河,主编.中医基础理论.第2版.上海:上海科学技术出版社,1984.37
    [45] 汪风炎,等.心理学研究的中国化.心理科学,2001,24(2):244
    [46] 吴涛,胡随瑜.肝气郁结证患者情绪状态的评估与血浆神经降压素水平的初步研究.湖南中医学院学报,2001,21(3):5-7
    [47] 胡随瑜,夏大胜,尤劲松.肝阳上亢证患者心理特征及血浆β-内啡肽水平研究.湖南中医学院学报,2000,20(4):6-8
    [48] Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 1996, 274(5292): 1527-1531
    [49] Lesch KP, Balling U, gross J, et al. Orgnization of human serotonin transporter gene. J Neural Transm Gen Seet, 1994, 95(2): 157-164
    [50] Bradley CC, Blakely RD. Alternative splicing of the human Sertonin transporter gene. J Neurochem, 1997, 69(4): 1356-1367
    [51] 罗学港主编.神经科学基础.第1版.长沙:中南大学出版社2002,48
    [52] Zalsman G, Frisch A, King RA, et al. Case control and family-based studues of tryptophan hydroxylase gene A218C polymorphism and suicidality in adolescents. Am J Med Genet, 2001, 105(5):451-457
    [53] Serretti A, Zanardi R, Cusin C, et al. Tryptophan Hydroxylase gene associated with paroxetine antidepressant activity. Eur Neuropsychopharmacol, 2001, 11 (5) :375-380
    [54] Du L, Bakish D, Hrdina PO. Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. J Affect Disord, 2001, 65(1):37-44
    
    
    [55] Nolan KA, Volavka J, Lachman HM, et al. An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorder. Psychiatr Genet, 2000, 10(3):109-115
    [56] Du L, Fuludi G, Palkovits M, et al. Tryptophan hydroxylase gene 218A/C polymorphism is not associated with depressed suicide. Int J Neuropsychopharmacol, 2000, 3(3):215-220
    [57] Ono H, Shirakawa O, Nishiguchi N, et al. Tryptophan hydroxylase gene polymorphisms are not associated with suicide. Am J Genet, 2000, 96(6):861-863
    [58] Serretti A, Lilli R, Lorenzi C, et al. Lack of association between tryptophan hydroxylase gene and psychotic symptomatology in schizophrenia, Schizophr Res, 1999, 40(2): 171-172
    [59] Arregui A, Mackay AVP, Spokes EG, et al. Reduced activity of angiotensin converting enzyme in basal ganglia in early onset schizophrenia. Psychol Med, 1980, 10(2): 307-313
    [60] Johnston CI. Biochemistry and pharmacology of renin-angiotensin system. Drugs, 1990, 39(suppl): 21-31
    [61] Jenkins TA, Medelsohn FA, Chai SY, et al. Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J Neurochem, 1997, 68(3): 1304-1311
    [62] Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin converting enzyme gene controls plasma ACE plasma ACE levels. Am J Hum Genet, 1992, 51(1): 197-205
    [63] Routledge C, Middlemiss DN. The 5-HT hypothesis of depression revisited. Mol Psychiatry, 1996, 1(6): 437
    [64] Tsai SJ, Hong CJ, Liu TY, et al. Association study for a functional serotonin transporter gene polymorphism and late-onset Alzheimer' s disease for Chinese patients. Neuropsychobiology, 2001, 44(1): 27-30
    [65] Liu W, Gu N, Feng G, et al. Tentative association of the serotonin
    
    transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han Chinese. Pharmacogenetics, 1999, 9(4): 491-495
    [66] Chong SA, Lee WL, Tan CH, et al. Attemped suicide and polymorphism of the serotonin transporter gene in Chinese patients with schizophrenia. Psychiatry Res, 2000, 97(23): 101-106
    [67] Tang GM, Ren DM, Xin RE, ET AL. Lack of association between the tryptophan hydroxylase gene A218C polymorphism and attention-deficit hyperactivity disorder in Chinese Han population. American Journal of Medical Genetics, 2001, 105(6): 485-488
    [68] Collier DA, Stober G, Li T, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Mol Psychiatry, 1996, 1(6): 453-460
    [69] Kunugi H, Hattori M, Kato T, et al. Serotonin transporter gene polymorphisms: ethic difference and possible association with bipolar affective disorder. Mol Psychiatry, 1997, 2(6): 457-462
    [70] Gelernter J, Kranzaler H, Cubells JF. serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria un African-and European-American and Japanese populations and in alcohol--dependent subjects. Hum Genet, 1997, 101(2): 243-246
    [71] Tsai SJ, Hong CJ, Liu TY, et al. Association study for a functional serotonin transporter gene polymorphism and late-Enset Alzheimer' s disease for Chinese patients. Neuropsychobiology, 2001, 44(1): 27-30
    [72] Liu W, Gu N, Feng G, et al. Tentative association of the serotonin transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han Chinese. Pharmacogenetics, 1999, 9(4): 491-495

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700